Combined dexamethasone/CRF test in remitted outpatients with recurrent major depressive disorder.
J Affect Disord
; 93(1-3): 259-63, 2006 Jul.
Article
in En
| MEDLINE
| ID: mdl-16677715
ABSTRACT
BACKGROUND:
Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis is a prominent neurobiological finding during a major depressive episode, reflecting a state dependent factor. An issue under investigation is whether the dysfunction of the HPA axis has also a role to play as a state-independent or trait factor for major depressive disorder (MDD). In relation to this, it is important to examine HPA axis function in patients who are clinically remitted from depression.METHODS:
Twenty-three remitted outpatients with recurrent MDD and 23 age- and gender-matched control individuals without a history of MDD participated in the sensitive combined dexamethasone/corticotropin-releasing factor (DEX/CRF) test.RESULTS:
Free salivary cortisol responses were not significantly different between the two groups, although three patients (13%) displayed extremely elevated cortisol responses after CRF.LIMITATIONS:
Limited sample size. All but one patient were under treatment with an antidepressant.CONCLUSIONS:
This study shows no evidence for a disturbed DEX/CRF test as a state-independent factor in recurrent MDD on a group level. However, MDD is a complex and heterogenic disorder. Probably, there is a subgroup of patients who show a disturbed DEX/CRF test due to an inherited and/or acquired predisposition or as a biological scar after previous depressive episodes.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Corticotropin-Releasing Hormone
/
Dexamethasone
/
Hydrocortisone
/
Depressive Disorder, Major
/
Ambulatory Care
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Affect Disord
Year:
2006
Document type:
Article
Affiliation country:
Belgium